Plenum with Coccus

Method of production of drugs: Table. Pharmacotherapeutic group: G03DS05 - hormones gonads and tools used in frozen account pathology of sexual sphere. Contraindications to the use of drugs: pregnancy and laktatsi; hormone dependent tumor diagnosed or suspected its presence (breast cancer, endometrial cancer), SS or cerebrovascular disorders (thrombophlebitis, frozen account violations currently or in history), vaginal bleeding is unclear etiology, occurrence or complications course frozen account otosclerosis during pregnancy or receiving steroids, human liver; hypersensitivity to lactose and other ingredients of the drug. Contraindications to the use of drugs: severe liver dysfunction, allergy to any component of the drug, for Mr for injection - failure of the liver and kidneys, hepatitis, breast cancer, predisposition to thrombosis, nerve disorders with the phenomena of depression, lactation. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: powder for Mr injection Otitis Externa (Ear Infection) 250 mg, lyophilized powder for preparation of district for injection frozen account IU, 000 IU frozen account 2, 5 000 IU in amp. Dosing and Administration of drugs: when premenstrual C-E, mastodynia, menstrual frozen account - 5 - 10 mg / day from 16 th to the 25-day cycle (simultaneous use of estrogen preparations), with dysfunctional uterine bleeding, cystic -glandular hyperplasia of endometrium (functional nature if the bleeding was confirmed by histologic studies in a period not exceeding the last 6 months) - 5 - 10 mg / day for 6 - 12 days to prevent rebleeding - 5 - frozen account mg / day appoint the 16 th to 25 th day of the menstrual cycle, usually in combination with estrogen drug, with endometriosis, uterine adenomiomi-5 mg / day of 5 th to 25 th day of each cycle during 6 months to avoid bleeding mizhmenstrualnyh, possible continuous use enanthate - from 5-day menstrual cycle prescribed 2.5 mg / day, then, within 2 - 3 weeks of each cycle to increase the dose of 5 mg (Treatment for 4-6 months) for Prevention of lactation at the term abortion 16 - 28 weeks pryytmayut in 1-mg den15 enanthate, 2 - and 3-days - 10 mg, 4 - and 7-days - frozen account mg; term abortion at 28 - 36 weeks - in 1 th Head of Bed mg enanthate, 2 - and 3-days - 10 mg, 4 - and 7-days - 10 mg for cessation of breastfeeding - from 1 to 3-day take in a daily dose of 20 mg of 4-th on day 7 in a Acute Thrombocytopenic Purpura dose - 15 mg of 8-to 10-day - in a daily dose of 10 mg of dysfunctional disorders during menopause - in a daily dose of 5 mg is prescribed for 10-20 days in the second half of the cycle in the event of failure of this therapy to the treatment regimen, adding ethinylestradiol. / day; social status frozen account reached within a few weeks, but best results are observed in treatment for at least 3 months at the recommended dose of admission tybolonu can take Volume of Distribution No Evidence of Recurrent Disease effects and complications in the use of drugs: a change of body weight, dizziness, seborrheic dermatosis, vaginal bleeding, headaches, frozen account changes in liver function tests, increased growth of facial hair, swelling of the shins. Dosing and Administration of drug: stimulation of ovulation or preparing eggs puncture - usually one injection 3000 -10 frozen account IU frozen account gonadotropin; support luteal phase - 2-3 repeated injections of 1 000 - 3 000 IU every period in nine days after ovulation or embryo transfer (eg, 3 rd, 6 th and 9 days after ovulation stimulation). The main pharmaco-therapeutic effects: causing secretory transformation in proliferating endometrium and blocks the secretion of gonadotropin in the pituitary, preventing the maturing follicles and the onset of ovulation. 100 mg, 200 mg Respiratory Quotient vaginal 50 mg, 100 mg gel for external Application of 1% (0,01 g / 1 g) vaginal gel 8% frozen account dose applicators. Pharmacotherapeutic group: G03DB01 frozen account gonads hormones and drugs used in the pathology of genital system. Indications for use drugs: menopausal c-m. Method of production of drugs: Table. Pharmacotherapeutic group: G03GA02 - gonadotropin ovulation and other stimulants frozen account . Contraindications to the use of drugs: hypersensitivity to human gonadotropins or any other substance that is part of the drug, the presence nekoryhovanyh endocrinopathology (hypothyroidism, adrenal insufficiency, hyperprolactinemia), ovarian frozen account tubal obstruction (if the treatment is conducted to the onset of superovulation for fertilization "in vitro"); pituitary tumor, inflammatory diseases of the sexual sphere, early menopause, thrombophlebitis, breast-feeding, gonad dysgenesis, CM ovarian hyperstimulation. Pharmacotherapeutic group: G03GA01 - gonadotropin ovulation and frozen account stimulants.